• 07/11/2024, Sophia Antipolis, France

    Financial communication schedule for the second half of 2024

    Median Technologies announces the publication date for its 2024 half year results and Q3, 2024 business activity: October 214, 2024 after close of trading
    Read more Download 20240711_PR_H1fincomm2024_EN.pdf
  • 07/05/2024, Sophia Antipolis, France

    Half year Median Technologies liquidity contract statement

    Resources listed under the liquidity contract entrusted by Median Technologies to TP ICAP (Europe) as of June 28, 2024.
    Read more Download 20240705_PR_liquiditycontHY12024_EN-1.pdf
  • 07/03/2024, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of June 30th, 2024

    Disclosure of total number of voting rights and number of shares in the capital as of June 30th, 2024, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20240703_PR_shares_votingrights_June2024.pdf
  • 06/07/2024, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of May 31st, 2024

    Disclosure of total number of voting rights and number of shares in the capital as of May 31st, 2024, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20240607_PR_shares_votingrights_May2024.pdf
  • 06/03/2024, Sophia Antipolis, France

    Median Technologies announces the availability of the preparatory documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 19, 2024

    The shareholders of Median Technologies are invited to participate in the Shareholders’ Ordinary and Extraordinary General Meeting which will be held on Wednesday June 19, 2024, at 5:00 pm CEST at PDGB, 174 avenue Victor Hugo – 75116 Paris.
    Read more Download 20240603_PR_OEGM_20240619_EN.pdf
  • 05/29/2024, Sophia Antipolis, France

    Median Technologies to participate in the 2024 ASCO Annual Meeting, May 31 – June 4, 2024, McCormick Place, Chicago, IL, USA

    Median Technologies will participate in the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting taking place from May 31 to June 4, McCormick Place, Chicago, IL, USA. The Median team, with iCRO and eyonis™ representatives will be pleased to welcome the ASCO participants at booth #15142, South Building, Hall A, McCormick place, from June 1 to 3 (exhibition dates), from 9:00 am to 5:00 pm.
    Read more Download 20240529_PR_ASCO2024_EN.pdf
  • 05/21/2024, Sophia Antipoliss, France

    Median Technologies, a world leading oncology clinical trial imaging services provider, becomes preferred vendor to another Top 3 pharmaceutical company.

    Median Technologies has been selected as a preferred clinical trial imaging services provider for another leading global pharmaceutical company. Median Technologies is now preferred provider for two of the Top 3 global pharma companies, based on oncology sales
    Read more Download 20240521_PR_Top3pharma-Median_Final_EN.pdf
  • 05/10/2024, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of April 30th, 2024

    Disclosure of total number of voting rights and number of shares in the capital as of April 30th, 2024, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20240510_PR_shares_votingrights_April2024.pdf
  • 04/25/2024, Sophia Antipolis, France

    Median Technologies reports full-year 2023 financial results and provides first quarter 2024 financial information.

    Median Technologies today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited) for the first quarter of 2024, as of March 31, 2024. The consolidated financial statements for the financial year ended December 31, 2023, were audited and approved by the Company’s Board of Directors on April 24, 2024.
    Read more Download 20240425_PR_annuals2023_Q12024_EN_final.pdf
  • 04/10/2024, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of March 31st, 2024

    Disclosure of total number of voting rights and number of shares in the capital as of March 31st, 2024, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20240410_PR_shares_votingrights_March2024-1.pdf